Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation

Experimental Neurology

Volumn 222, Issue 1, 2010, Pages 30-41

  Gallina, Pasquale ^a   Paganini, Marco ^a   Lombardini, Letizia ^a   Mascalchi, Mario ^a   Porfirio, Berardino ^a   Gadda, Davide ^a   Marini, Mirca ^a   Pinzani, Pamela ^a   Salvianti, Francesca ^a   Crescioli, Clara ^a   Bucciantini, Sandra ^a   Mechi, Claudia ^a   Sarchielli, Erica ^a   Romoli, Anna Maria ^a   Bertini, Elisabetta ^a   Urbani, Serena ^a   Bartolozzi, Benedetta ^a   De Cristofaro, Maria Teresa ^a   Piacentini, Silvia ^a   Saccardi, Riccardo ^a   Pupi, Alberto ^a   Vannelli, Gabriella Barbara ^a   Di Lorenzo, Nicola ^a   more..

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Brain repair; Cell migration; Fetal neural transplant; Huntington's disease; Neurotransplantation; Striatum

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADULT; ARTICLE; ATTENTION; CASE REPORT; CAUDATE NUCLEUS; CORPUS STRIATUM; FEMALE; FETAL TISSUE TRANSPLANTATION; FOLLOW UP; FRONTAL CORTEX; FUNCTIONAL STATUS; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MALE; MOTOR PERFORMANCE; NERVE CELL NETWORK; NERVE TRANSPLANTATION; NEUROBLAST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DIFFERENTIATION; TISSUE GROWTH; WORKING MEMORY;

ADULT; BRAIN TISSUE TRANSPLANTATION; CELL MOVEMENT; CORPUS STRIATUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HLA ANTIGENS; HUMANS; HUNTINGTON DISEASE; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROLOGIC EXAMINATION; PROTEIN BINDING; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77649338570     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.12.005     Document Type: Article

References (40)

1. Bachoud-Lévi A.C., Bourdet C., Brugières P., Nguyen J.P., Grandmougin T., Haddad B., Jény R., Bartolomeo P., Boissè M.F., Barba G.D., Degos J.D., Ergis A.M., Lefaucher J.P., Lisovoski F., Pailhours E., Rémy P., Palfi S., Defer G.L., Cesaro P., Hantraye P., Peschanski M. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neurol. 2000, 161:194-202.
2. Bachoud-Lévi A.C., Rémy P., Nguyen J.P., Brugières P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., Boissé M.F., Grandmougin T., Jény R., Bartolomeo P., Dalla Barba G., Degos J.D., Lisovoski F., Ergis A.M., Pailhours E., Cesaro P., Hantraye P., Peschanski M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000, 356:1975-1979.
3. Bachoud-Lévi A.C., Gaura V., Brugieres P., Lefaucheur J.P., Boissé M.F., Maison P., Baudic S., Ribeiro M.J., Bourdet C., Rémy P., Cesaro P., Hantraye P., Peschanski M. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 2006, 5:303-309.
4. Bantubungi K., Blum D., Cuvelier L., Wislet-Gendebien S., Rogister B., Brouillet E., Schiffmann S.N. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease. Mol. Cell. Neurosci. 2008, 37:454-470.
5. Björklund A., Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 2000, 3:537-544.
6. Canals J.M., Pineda J.R., Torres-Peraza J.F., Bosch M., Martin-Ibanez R., Munoz M.T., Mengod G., Ernfors P., Alberch J. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci. 2004, 24:7727-7739.
7. Capetian P., Knoth R., Maciaczyk J., Pantazis G., Ditter M., Bokla L., Landwehrmeyer G.B., Volk B., Nikkhah G. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009, 160:661-675.
8. Cicchetti F., Saporta S., Hauser A., Parent M., Saint-Pierre M., Sanberg P.R., Li X.J., Parker J.R., Chu Y., Mufson E.J., Kordower J.H., Freeman T.B. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc. Nat. Acad. Sci. USA 2009, 106:12483-12488.
9. Clelland C.D., Barker R.A., Watts C. Cell therapy in Huntington disease. Neurosurg. Focus 2008, 24:E9.
10. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., Mostoslavsky G., Serre A.C., Snyder E.Y., Yoo J.J., Furth M.E., Soker S., Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nat. Biotechnol. 2007, 25:100-106.
11. Doetsch F. The glia identity of neural stem cells. Nat. Neurosci. 2003, 6:1127-1134.
12. Dunnet S.B., Rosser A.E. Cell transplantation for Huntington's disease: should we continue?. Brain Res. Bull. 2007, 72:132-147.
13. Dunnett S.B., Rosser A.E. Stem cell transplantation for Huntington's disease. Exp Neurol. 2007, 203:279-292.
14. Freeman T.B., Cicchetti F., Hauser R.A., Deacon T.W., Li X.J., Hersc S.M., Nauert G.M., Sanberg P.R., Kordower J.H., Saporta S., Isacson O. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc. Nat. Acad. Sci. USA 2000, 97:13877-13882.
15. Gaillard A., Prestoz L., Dumartin B., Cantereau A., Morel F., Roger M., Jaber M. Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nat. Neurosci. 2007, 10:1294-1299.
16. Gallina P., Paganini M., Lombardini L., Saccardi R., Marini M., De Cristoforo M.T., Pinzani P., Salvianti F., Crescioli C., Di Rita A., Bucciantini S., Mechi C., Sarchielli E., Moretti M., Piacentini S., Gritti G., Bosi A., Sorbi S., Orlandini G., Vannelli G.B., Di Lorenzo N. Development of human striatal anlagen after transplantation in a patient with Huntington's disease. Exp. Neurol. 2008, 213:241-244.
17. Gallina P., Paganini M., Di Rita A., Lombardini L., Moretti M., Vannelli G.B., Di Lorenzo N. Human fetal striatal transplantation in Huntington's disease: a refinement of the stereotactic procedure. Stereotact. Funct. Neurosurg. 2008, 86:308-313.
18. Hammerman M.R. Windows of opportunity for organogenesis. Transpl. Immunol. 2002, 15:1-8.
19. Hauser R.A., Furtado S., Cimino C.R., Delgado H., Eichler S., Schwartz S., Scott D., Nauert G.M., Soety E., Sossi V., Holt D.A., Sanberg P.R., Stoessl A.J., Freeman T.B. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002, 58:687-695.
20. Unified Huntington's disease rating scale: reliability and consistency. Mov. Disord. 1996, 11:136-142. Huntington's Study Group.
21. Hurelbrink C.B., Barker R.A. Migration of cells from primary transplants of allo- and xenogratfted foetal striatal tissue in the adult rat brain. Eur. J. Neurosci. 2005, 21:1503-1510.
22. Hurelbrink C.B., Armstrong R.J., Dunnett S.B., Rosser A.E., Barker R.A. Neural cells for primary human striatal xenografts migrate extensively in the adult rat CNS. Eur. J. Neurosci. 2002, 15:1255-1266.
23. Keene C.D., Sonnen J.A., Swanson P.D., Kopyov O., Reverenz J.B., Montine T.J. Neural transplantation in Huntington's disease. Long-term grafts in two patients. Neurology 2007, 68:2093-2098.
24. Keene C.D., Chang R.C., Leverenz J.B., Kopyiov O., Pelman S., Hevner R.F. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol 2009, 117:329-338.
25. Ko I.K., Kato K., Iwata H. Antibody microarray for correlating cell phenotype with surface marker. Biomaterials 26, 687- 2005, 696.
26. Kopyov O.V., Jacques S., Lieberman A., Duma C.M., Eagle K.S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 1998, 149:97-108.
27. Krystkowiak, P., Gaura, V., Labalette, M., Rialland, A., Remy, P., Peschanski, M., Bachoud-Lévi, A.C., 2007. Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS ONE 2, e166.
28. Lepore A.C., Neuhuber B., Connors T.M., Han S.S., Liu Y., Daniels M.P., Rao M.S., Fischer I. Long-term fate of neural precursor cells following transplantation into developing and adult CNS. Neuroscience 2006, 142:287-304.
29. Li X., Xu J., Bai Y., Wang X., Dai X., Liu Y., Zhang J., Zou J., Shen L., Li L. Isolation and characterization of neural stem cells from human fetal striatum. Biochem. Biophys. Res. Commun. 2005, 326:425-434.
30. Mai J.K., Krajewski S., Reifenberger G., Genderski B., Lensing-Höhn S., Ashwell K.W. Spatiotemporal expression gradients of the arbohydrate antigen (CD15) (Lewis X) during development of the human basal ganglia. Neuroscience 1999, 88:847-858.
31. Marin O., Valdeolmillos M., Moya F. Neurons in motion: same principles for different shapes. Trends Neurosci. 2006, 12:655-661.
32. Pruszak J., Ludwig W., Blak A., Alavian K., Isacson O. CD15, CD24 and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells. 2009, Electronic publication ahead of print.
33. Quinn N., Brown R., Craufurd D., Goldman S., Hodges J., Kieburtz K., Lindvall O., MacMillan J., Roos R. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov. Disord. 1996, 11:143-150.
34. Reuter I., Tai Y.F., Pavese N., Chaudhuri K.R., Mason S., Polkey C.E., Clough C., Brooks D.J., Barker R.A., Piccini P. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J. Neurol. Neurosurg. Psychiatry 2008, 79:948-951.
35. Rosser A.E., Barker R.A., Harrower T., Watts C., Farrington M., Ho A.K., Burnstein R.M., Menon D.K., Gillard J.H., Pickard J., Dunnett S.B. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475. J. Neurol. Neurosurg. Psychiatry 2002, 73:678-685. NEST-UK.
36. Silva J., Nichols J., Theunissen T.W., Guo G., van Oosten A.L., Barrandon O., Wray J., Yamanaka S., Chambers I., Smith A. Nanog is the gateway to the pluripotent ground state. Cell 2009, 138:722-737.
37. Skaper S.D. The biology of neurotrophins, signaling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol. Disord. Drug. Targets 2008, 7:46-62.
38. Tabar V, Panogiotakos G, Greenberg ED, Chan BK, Sadelain M, Gutin PH, Studer L. Migration and differentiation of neural precursors derived from human embryonic stem cells in the rat brain. Nat. Biotechnol. 2005, 23:601-606.
39. Tuszynski M.H. Rebuilding the brain: resurgence of fetal grafting. Nat. Neurosci. 2007, 10:1229-1230.
40. Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 2007, 81:294-330.